Tag: Real-world evidence

A new real-world study of 144 US patients shows the first once-daily single-tablet macitentan/tadalafil combination for pulmonary arterial hypertension is ...

A large real-world study finds that GLP-1 receptor agonists are associated with significantly reduced risks of heart failure, pulmonary hypertension, ...

A nationwide analysis of French hospital cohorts finds that only about two-thirds of small-cell lung cancer patients eligible for G-CSF ...

A retrospective real-world study from Milan's San Raffaele institute compares ocrelizumab and ofatumumab as successor therapies for multiple sclerosis patients ...

A real-world cohort of 126 Chinese patients shows trastuzumab deruxtecan delivers a median 9.1 months of progression-free survival in HER2-low ...

A new systematic review finds that about one in five adults with diffuse large B-cell lymphoma develops febrile neutropenia during ...

A multicenter Central European real-world study finds sacituzumab govitecan delivers meaningful survival benefit and manageable toxicity in heavily pretreated metastatic ...

A systematic review of five real-world studies finds that a biweekly gemcitabine and nab-paclitaxel schedule matches standard survival outcomes in ...

A real-world study of 214 patients finds that adding Bevacizumab to Olaparib maintenance therapy significantly improves overall survival only in ...

In recent years, the intersection of mental health disorders and substance use disorders (SUD) in individuals living with HIV has ...

In the ongoing battle against metastatic HER2-positive breast cancer, a new in-depth study from Greece sheds crucial light on the ...

In the evolving landscape of hemophilia treatment, a recent study sheds light on the comparative effectiveness of prophylactic therapies for ...